Recent Blog Posts

View Post: User:Coleenmryanc
18 Nov 2009 by Coleenmryanc  
The clinical duration of the intubating dose was 34 /-6.9 minutes in the rocuronium <blockquote>online pharmacies oxycontin</blockquote> group, vs. This painful form of arthritis can affect anyone, but is most prevalent among patients ...
View Blog: East Bonner County Library District Wiki... - http://wiki.ebcld.org/index.php?title=Main_Page

---

View Post: European Union</b>'s CHMP Issues Positive Opinion on Schering ...
3 Jun 2008
Upon European approval, sugammadex will be the first and only selective relaxant binding agent (SRBA) and will enable anesthesiologists to rapidly and predictably reverse both moderate and deep muscle relaxation induced by rocuronium ...
View Blog: BioSpace.com Featured News and Stories - http://www.biospace.com/

---

View Post: Ketamine facilitates RSI
17 Nov 2009 by drcd2009  
PURPOSE: Both ketamine and priming may shorten the onset time of rocuronium. This study investigates the effects of ketamine and priming as components of a propofol induction on intubating conditions and onset of neuromuscular block. ...
View Blog: Halaman Sains Perubatan Kecemasan - http://drcd2009.wordpress.com/

---

View Post: Rocuronium vs. Succinylcholine in the Emergency Department: A ...
28 Aug 2009 by coptermedic  
Background: Two methods of paralysis are available for rapid sequence intubation (RSI) in the emergency department (ED): depolarizing agents such as succinylcholine, and non-depolarizing drugs such as rocuronium. Rocuronium is a useful ...
View Blog: The ACUTE CARE Blog: Non-Urban Emergency Medicine - http://acutecareinc.wordpress.com/

---

View Post: Reversal of rocuronium-induced neuromuscular blockade
12 Oct 2009 by Administrator  
BACKGROUND: Sugammadex reverses neuromuscular blockade by chemical encapsulation of rocuronium. This phase IIIA study explored efficacy and safety of sugammadex in infants (28 days to 23 months), children (2-11 yr), adolescents (12-17 ...
View Blog: Medical Index - http://medicalindex.asia/

---

View Post: app pharmaceuticals launches rocuronium bromide injection
27 Jul 2009 by debatedurex  
app pharmaceuticals, inc., a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced that it has launched rocuronium bromide injection, the generic equivalent of organon's zemuron®. ...
View Blog: debatedurex - http://debatedurex.devpad.in/

---